| P50 | author | Michael Schemann | Q37383877 |
| P2093 | author name string | M M Wouters | |
| | Y Nasser | |
| | S Vanner | |
| | G E Boeckxstaens | |
| P2860 | cites work | Role for protease activity in visceral pain in irritable bowel syndrome | Q22241892 |
| | The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome | Q28288581 |
| | Cellular and Molecular Mechanisms of Pain | Q29011961 |
| | Functional bowel disorders | Q29620328 |
| | Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome | Q33314697 |
| | Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome | Q33481455 |
| | Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia | Q33805605 |
| | Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS. | Q45189883 |
| | Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons | Q46258357 |
| | Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome | Q46431252 |
| | Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients | Q46684728 |
| | Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2. | Q47746673 |
| | Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship? | Q47926641 |
| | Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. | Q48492553 |
| | Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. | Q51010528 |
| | Mast cell tryptase reduces junctional adhesion molecule-A (JAM-A) expression in intestinal epithelial cells: implications for the mechanisms of barrier dysfunction in irritable bowel syndrome. | Q51067173 |
| | Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. | Q51660489 |
| | Serotonin transporter gene polymorphism and irritable bowel syndrome. | Q53586811 |
| | Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome. | Q53595244 |
| | Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. | Q53622343 |
| | The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. | Q54319433 |
| | SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine. | Q54324853 |
| | Differential expression of toll-like receptors in patients with irritable bowel syndrome. | Q54400679 |
| | Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. | Q54451070 |
| | Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS. | Q54491760 |
| | Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. | Q54513905 |
| | Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome | Q56985161 |
| | Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome | Q56996391 |
| | Submucous rather than myenteric neurons are activated by mucosal biopsy supernatants from irritable bowel syndrome patients | Q57097924 |
| | MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome | Q33939639 |
| | Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients. | Q33987389 |
| | Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions | Q34094755 |
| | Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. | Q34297954 |
| | Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype | Q34426677 |
| | Review article: intestinal serotonin signalling in irritable bowel syndrome | Q34566461 |
| | Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome | Q34606239 |
| | Elevated expression of c-fos in central nervous system correlates with visceral hypersensitivity in irritable bowel syndrome (IBS): a new target for IBS treatment | Q35120008 |
| | Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome | Q35362266 |
| | Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis | Q35596747 |
| | Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. | Q35761348 |
| | Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome | Q35837381 |
| | Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea | Q36494385 |
| | Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome | Q36776163 |
| | Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain | Q36930795 |
| | Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome | Q37390132 |
| | Functions and imaging of mast cell and neural axis of the gut. | Q37580697 |
| | Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit | Q37716041 |
| | Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome | Q37871421 |
| | Bacterial proteases in IBD and IBS. | Q37928851 |
| | Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome | Q37954521 |
| | Intestinal barrier function in health and gastrointestinal disease | Q38009940 |
| | Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome | Q38029994 |
| | Novel functional roles for enteric glia in the gastrointestinal tract. | Q38034376 |
| | Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. | Q38052154 |
| | Genetics of human gastrointestinal sensation | Q38099692 |
| | Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? | Q38104610 |
| | Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome | Q40402334 |
| | Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. | Q42462847 |
| | Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase | Q42466084 |
| | Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes | Q42509169 |
| | Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome | Q43124191 |
| | Sensitivity testing in irritable bowel syndrome with rectal capsaicin stimulations: role of TRPV1 upregulation and sensitization in visceral hypersensitivity? | Q43420598 |
| | Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome | Q44520650 |
| | Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. | Q44779671 |
| | Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome | Q45074387 |
| P433 | issue | 4 | |
| P921 | main subject | biopsy | Q179991 |
| | pathogenesis | Q372016 |
| P304 | page(s) | 455-469 | |
| P577 | publication date | 2014-02-14 | |
| P1433 | published in | Neurogastroenterology and Motility | Q15767493 |
| P1476 | title | Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome | |
| P478 | volume | 26 | |